Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$272,001
+$29,273 QoQ
Shares Held
1,071
+7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#4,259
of 4,676 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026True Link Financial Advisors, LLC holds $881,489 across 3 Drug Manufacturers - General names. JNJ ranks #2 (30.9% of the industry book) .
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272,001 | 1,071 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $242,728 | 993 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $215,228 | 1,040 | Shares | Sole | 2026-01-29 | |
| 2025-06-30 | $205,296 | 1,344 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $263,353 | 1,588 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $257,568 | 1,781 | Shares | Sole | 2025-01-16 | |
| 2023-09-30 | $449,494 | 2,886 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $417,110 | 2,520 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $390,600 | 2,520 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $445,158 | 2,520 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $411,667 | 2,520 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $447,325 | 2,520 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $434,036 | 2,449 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $418,950 | 2,449 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $357,561 | 2,214 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $282,364 | 1,714 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $281,695 | 1,714 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $312,714 | 1,987 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||